news Biovac and IVI sign ground breaking deal for the manufacturing of OCV 24 November 2022 | By Izzy Wood (Drug Target Review) Biovac signs deal with IVI to develop and manufacture oral cholera vaccine (OCV) for African and global markets.
news SK bioscience collaborates with IVI to support global R&D 21 November 2022 | By Izzy Wood (Drug Target Review) SK bioscience and IVI convened in consultative meeting to discuss cooperation for next pandemic and announced KRW3 billion donation to IVI to support advancement of global vaccine R&D